oxazoles has been researched along with Cancer of Lung in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (24.32) | 18.7374 |
| 1990's | 3 (8.11) | 18.2507 |
| 2000's | 12 (32.43) | 29.6817 |
| 2010's | 8 (21.62) | 24.3611 |
| 2020's | 5 (13.51) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, D; Bekaii-Saab, T; Walden, D | 1 |
| Chen, M; Dong, J; Gao, Y; Liu, W; Wang, T; Zhu, D | 1 |
| Chen, C; Dai, M; Li, H; Wang, D; Wang, W; Wu, L | 1 |
| Azam, SH; Fussell, SC; Hwang, D; Kabanov, AV; Pecot, CV; Sokolsky-Papkov, M; Van Swearingen, AED; Vinod, N; Wayne, E | 1 |
| Ameratunga, M; Aspegren, J; Bono, P; Braña, I; de Bono, JS; Korjamo, T; Plummer, R; Postel-Vinay, S; Snapir, A | 1 |
| Li, XF; Liu, J; Wang, HT; Wang, WY; Xu, JP; Ye, W; Zhou, ZZ | 1 |
| Jeong, JH; Jo, HR; Kang, MA; Kim, MH; Kim, W; Shin, YJ | 1 |
| Allingham, JS; Craig, AW; Evans, PA; Nersesian, S; Newsted, D; Shah, K; Williams, R; Young, S | 1 |
| Inoue, K; Jiang, YZ; Kang, D; Li, G; Min, JZ; Morota, Y; Todoroki, K; Toyo'oka, T; Yu, HF | 1 |
| Chen, DQ; Ding, J; Geng, MY; Liu, HC; Shen, AJ; Shen, JK; Sun, JY; Wang, X; Wang, YQ; Xiong, B; Zhang, MM; Zheng, M | 1 |
| Habib, AA; Kodym, E; Kodym, R; Reis, AE; Saha, D; Story, MD | 1 |
| Bergs, JW; Buist, MR; Darroudi, F; Franken, NA; Haveman, J; Jaarsma, PA; Medema, JP; Rodermond, HM; Stalpers, LJ; Ten Cate, R; Van Bree, C | 1 |
| Higashi, T; Inagaki, S; Matsumoto, A; Min, JZ; Shi, Q; Toyo'oka, T; Yano, H; Yu, HF | 1 |
| Byun, JY; Cha, MY; Choi, KJ; Jung, YH; Kang, SJ; Kim, MS; Lee, GS; Lee, HJ; Lee, KO; Park, SB; Song, JY | 1 |
| Bae, SY; Jeon, JE; Kim, GD; Lee, SK; Shin, J | 1 |
| Hida, T; Ito, H; Kozaki, K; Matsuo, K; Miyaishi, O; Ogawa, M; Sugiura, T; Suzuki, T; Takahashi, T; Tatematsu, Y | 1 |
| Davenport, R; Herald, DL; Knight, JC; Pettit, GR; Pettit, RK; Schmidt, JM; Tucker, BE | 1 |
| Amaya, M; Amirkhosravi, A; Blaydes, S; Desai, H; Francis, JL; Meyer, T; Mousa, SA | 1 |
| Enomoto, M; Gonda, T; Higuchi, T; Kobayashi, H; Sugihara, K; Uetake, H | 1 |
| Cress, WD; Freeman, SN; Ma, Y | 1 |
| Enomoto, M; Higuchi, T; Kobayashi, H; Sugihara, K; Uetake, H | 1 |
| Ali, MA; Carreon, P; Choy, H; Mukhopadhyay, P; Nandi, A; Saha, D | 1 |
| Esumi, H; Ikeda, D; Kawada, M; Kunimoto, S; Masuda, T; Ohba, S; Osono, M | 1 |
| Boon-Unge, K; Govitrapong, P; Yu, Q; Zhou, A; Zhou, J; Zou, T | 1 |
| Janiak, M; Roszkowski, K; Roszkowski, W; Szmigielski, S; Wrembel, JM | 1 |
| Cooney, DA; Kensler, TW; Reck, LJ | 1 |
| Bärtsch, P; Eckes, S; Mairbäurl, H; Schulz, S; Wodopia, R | 1 |
| Hatano, K; Ishihara, S; Kitayama, J; Muto, T; Nagawa, H; Nita, ME; Osada, T; Shibata, Y; Sunami, E; Tomozawa, S; Tsuno, N; Tsuruo, T; Yano, H | 1 |
| Chalfant, CE; Hannun, YA; Obeid, LM; Ogretmen, B; Pinkerman, RL; Rathman, K; Wood, RE | 1 |
| De Gaetano, G; Donati, MB; Mussoni, L; Poggi, A | 1 |
| Schmähl, D; Wiessler, M | 1 |
| Bitonti, AJ; Dumont, JA; Jones, WD | 1 |
| Futami, H; Irino, S; Shiotani, T; Yamaji, Y; Yamauchi, N | 1 |
| Eisenhauer, E; Maksymiuk, A; Maroun, JA; Pater, J; Stewart, DJ; Young, V | 1 |
| Huber, KR; Roberts, J; Rosenfeld, H | 1 |
| Birch, R; Greco, A; Johnson, R; Kramer, BS; Prestridge, K | 1 |
| Huber, KR; Mayer, EP; Mitchell, DF; Roberts, J | 1 |
2 trial(s) available for oxazoles and Cancer of Lung
| Article | Year |
|---|---|
First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents; Biological Availability; Blood Platelets; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Fatigue; Female; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Neoplasms; Ovarian Neoplasms; Oxazoles; Prostatic Neoplasms, Castration-Resistant; Proteins; Pyridines; Quinolines; Sarcoma; Small Cell Lung Carcinoma; Young Adult | 2020 |
Phase II evaluation of acivicin in lung cancer: a Southeastern Cancer Study Group Trial.
Topics: Antibiotics, Antineoplastic; Carcinoma, Bronchogenic; Central Nervous System Diseases; Clinical Trials as Topic; Drug Evaluation; Hematologic Diseases; Humans; Isoxazoles; Lung Neoplasms; Oxazoles | 1986 |
35 other study(ies) available for oxazoles and Cancer of Lung
| Article | Year |
|---|---|
Tucatinib: an investigational novel therapeutic agent for the treatment of HER-2 colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Drugs, Investigational; Female; Humans; Lung Neoplasms; Oxazoles; Protein Kinase Inhibitors; Pyridines; Quinazolines; Receptor, ErbB-2; Trastuzumab | 2022 |
Mubritinib enhanced the inhibiting function of cisplatin in lung cancer by interfering with mitochondrial function.
Topics: Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cisplatin; Humans; Lung Neoplasms; Mice; Mitochondria; Oxazoles; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Triazoles | 2022 |
PPARα ligand, AVE8134, and cyclooxygenase inhibitor therapy synergistically suppress lung cancer growth and metastasis.
Topics: Animals; Antineoplastic Agents; Benzoates; Bezafibrate; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclooxygenase Inhibitors; Cytochrome P450 Family 2; Drug Evaluation, Preclinical; Drug Therapy, Combination; Eicosanoids; Indomethacin; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasm Metastasis; Neovascularization, Pathologic; Oxazoles; PPAR alpha; Pyrimidines; Treatment Outcome; Xenograft Model Antitumor Assays | 2019 |
High-capacity poly(2-oxazoline) formulation of TLR 7/8 agonist extends survival in a chemo-insensitive, metastatic model of lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adjuvants, Immunologic; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Oxazoles; Toll-Like Receptor 7; Toll-Like Receptor 8; Tumor Microenvironment | 2020 |
Discovery of novel trimethoxyphenylbenzo[d]oxazoles as dual tubulin/PDE4 inhibitors capable of inducing apoptosis at G2/M phase arrest in glioma and lung cancer cells.
Topics: Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Glioma; Humans; Lung Neoplasms; Molecular Structure; Oxazoles; Phosphodiesterase 4 Inhibitors; Structure-Activity Relationship; Tubulin; Tubulin Modulators; Tumor Cells, Cultured | 2021 |
Anticancer and radiosensitizing effects of the cyclin-dependent kinase inhibitors, AT7519 and SNS‑032, on cervical cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinases; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Lung Neoplasms; Mice; Oxazoles; Piperidines; Pyrazoles; Radiation-Sensitizing Agents; Thiazoles; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2018 |
Effects of Modulating Actin Dynamics on HER2 Cancer Cell Motility and Metastasis.
Topics: Ado-Trastuzumab Emtansine; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Drug Synergism; Female; Humans; Lung Neoplasms; Marine Toxins; Maytansine; Mice; Ovarian Neoplasms; Oxazoles; Receptor, ErbB-2; Trastuzumab; Xenograft Model Antitumor Assays | 2018 |
Rapid and sensitive determination of diacetylpolyamines in human fingernail by ultraperformance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
Topics: Adult; Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Diamines; Female; Humans; Limit of Detection; Linear Models; Lung Neoplasms; Male; Methanol; Middle Aged; Nails; Oxazoles; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Spermine; Sulfonamides; Tandem Mass Spectrometry | 2014 |
Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; ErbB Receptors; Female; Gefitinib; Heterografts; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Mutation; Neoplasm Transplantation; Oxazoles; Quinazolines; Resorcinols | 2016 |
The small-molecule CDK inhibitor, SNS-032, enhances cellular radiosensitivity in quiescent and hypoxic non-small cell lung cancer cells.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Hypoxia; Cell Line, Tumor; Cyclin-Dependent Kinases; Humans; Lung Neoplasms; Oxazoles; Radiation Tolerance; Thiazoles | 2009 |
Transient inhibition of Calyculin A induced premature chromosome condensation by hyperthermia.
Topics: Carcinoma, Squamous Cell; CDC2 Protein Kinase; Cell Line, Tumor; Chromatin Assembly and Disassembly; Chromosome Aberrations; Cyclin B; Cyclin B1; Cyclin-Dependent Kinases; Female; Fever; Histones; Humans; Hyperthermia, Induced; Lung Neoplasms; Marine Toxins; Oxazoles; Phosphorylation; Uterine Cervical Neoplasms | 2009 |
Simultaneous determination of polyamines in human nail as 4-(N,N-dimethylaminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole derivatives by nano-flow chip LC coupled with quadrupole time-of-flight tandem mass spectrometry.
Topics: Adult; Case-Control Studies; Chromatography, Liquid; Clinical Chemistry Tests; Female; Humans; Hydrophobic and Hydrophilic Interactions; Lung Neoplasms; Male; Middle Aged; Nails; Nanotechnology; Oxazoles; Polyamines; Reproducibility of Results; Sulfonamides; Tandem Mass Spectrometry; Time Factors; Young Adult | 2011 |
Synthesis and biological evaluation of pyrimidine-based dual inhibitors of human epidermal growth factor receptor 1 (HER-1) and HER-2 tyrosine kinases.
Topics: Acrylamides; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; ErbB Receptors; Female; Humans; Lapatinib; Lung Neoplasms; Mice; Mice, Inbred ICR; Models, Molecular; Mutation; Oxazoles; Pyrimidines; Quinazolines; Rats; Rats, Sprague-Dawley; Receptor, ErbB-2; Stomach Neoplasms; Structure-Activity Relationship | 2012 |
Anti-proliferative effect of (19Z)-halichondramide, a novel marine macrolide isolated from the sponge Chondrosia corticata, is associated with G2/M cell cycle arrest and suppression of mTOR signaling in human lung cancer cells.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line, Tumor; Cell Proliferation; G2 Phase; G2 Phase Cell Cycle Checkpoints; Humans; Lung Neoplasms; Macrolides; Mitogen-Activated Protein Kinases; Oxazoles; Porifera; Signal Transduction; TOR Serine-Threonine Kinases | 2013 |
Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a selective cyclooxygenase 2 inhibitor, JTE-522, and conventional anticancer agents.
Topics: Adenocarcinoma; Animals; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Cell Division; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; In Vitro Techniques; Isoenzymes; Lung Neoplasms; Membrane Proteins; Mice; Mice, Nude; Neoplasm Transplantation; Oxazoles; Paclitaxel; Prostaglandin-Endoperoxide Synthases; Taxoids; Tumor Cells, Cultured; Vinblastine; Vinorelbine | 2002 |
Isolation of labradorins 1 and 2 from Pseudomonas syringae pv. coronafaciens.
Topics: Crystallography, X-Ray; Deoxycholic Acid; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Molecular Conformation; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Oxazoles; Pancreatic Neoplasms; Pseudomonas; Tumor Cells, Cultured | 2002 |
Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454.
Topics: Administration, Oral; Alanine; Animals; Carcinoma, Lewis Lung; Cell Line, Tumor; Drug Evaluation, Preclinical; Female; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Metastasis; Oxazoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia | 2003 |
JTE-522, a selective COX-2 inhibitor, interferes with the growth of lung metastases from colorectal cancer in rats due to inhibition of neovascularization: a vascular cast model study.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Benzenesulfonates; Cell Line, Tumor; Colorectal Neoplasms; Cyclooxygenase 2; Enzyme Inhibitors; Isoenzymes; Logistic Models; Lung Neoplasms; Male; Microcirculation; Microscopy, Electron, Scanning; Neovascularization, Pathologic; Oxazoles; Prostaglandin-Endoperoxide Synthases; Pulmonary Circulation; Rats; Rats, Inbred F344 | 2004 |
E2F4 deficiency promotes drug-induced apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Cycle Proteins; DNA-Binding Proteins; E2F Transcription Factors; E2F1 Transcription Factor; E2F4 Transcription Factor; Fibroblasts; Flavonoids; Humans; Lung Neoplasms; Mice; Mice, Knockout; Oxazoles; Piperidines; Protein Kinase Inhibitors; Purines; RNA, Small Interfering; Roscovitine; Thiazoles; Transcription Factors; Tumor Cells, Cultured | 2004 |
JTE-522, a selective COX-2 inhibitor, inhibits growth of pulmonary metastases of colorectal cancer in rats.
Topics: Animals; Benzenesulfonates; Colorectal Neoplasms; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Lung; Lung Neoplasms; Organ Size; Oxazoles; Rats; Rats, Inbred F344; Vascular Endothelial Growth Factor A | 2005 |
The cyclin-dependent kinase 2 inhibitor down-regulates interleukin-1beta-mediated induction of cyclooxygenase-2 expression in human lung carcinoma cells.
Topics: Carcinoma, Non-Small-Cell Lung; CCAAT-Enhancer-Binding Proteins; Cell Line, Tumor; Cyclin-Dependent Kinase 2; Cyclooxygenase 2; Dinoprostone; Down-Regulation; Enzyme Induction; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Interleukin-1; Lung Neoplasms; Oxazoles; Promoter Regions, Genetic; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Thiazoles; Transcription, Genetic; Transfection | 2006 |
Antitumor effect of kigamicin D on mouse tumor models.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Colonic Neoplasms; Disease Models, Animal; Doxorubicin; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Oxazoles; Pancreatic Neoplasms; Xenograft Model Antitumor Assays | 2006 |
Emetine regulates the alternative splicing of Bcl-x through a protein phosphatase 1-dependent mechanism.
Topics: Alternative Splicing; bcl-X Protein; Breast Neoplasms; Cell Line, Tumor; Cycloheximide; Down-Regulation; Emetine; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Marine Toxins; Okadaic Acid; Oxazoles; Prostatic Neoplasms; Protein Phosphatase 1; Protein Phosphatase 2; Up-Regulation; Uterine Cervical Neoplasms | 2007 |
Effect of whole-body microwave hyperthermia on delayed cutaneous hypersensitivity in tumor-bearing mice.
Topics: Animals; Body Temperature; Hypersensitivity, Delayed; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Microwaves; Oxazoles; Sarcoma, Experimental; Skin | 1980 |
Therapeutic effects of acivicin and N-(phosphonacetyl)-L-aspartic acid in a biochemically designed trial against a N-(phosphonacetyl)-L-aspartic acid-resistant variant of the Lewis lung carcinoma.
Topics: Animals; Aspartate Carbamoyltransferase; Aspartic Acid; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Carcinoma; Drug Therapy, Combination; Glycine; Isoxazoles; Ligases; Lung Neoplasms; Neoplasms, Experimental; Organophosphorus Compounds; Oxazoles; Phosphonoacetic Acid; Pyrimidines; Rats | 1981 |
Impairment of cation transport in A549 cells and rat alveolar epithelial cells by hypoxia.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Amiloride; Animals; Carrier Proteins; Cations, Monovalent; Cell Hypoxia; Cell Membrane; Cells, Cultured; Enzyme Inhibitors; Epithelial Cells; Humans; Kinetics; Lung Neoplasms; Marine Toxins; Oxazoles; Potassium; Pulmonary Alveoli; Rats; Sodium; Sodium-Potassium-Chloride Symporters; Sodium-Potassium-Exchanging ATPase; Tumor Cells, Cultured | 1997 |
Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522.
Topics: Animals; Benzenesulfonates; Cell Division; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Isoenzymes; Lung Neoplasms; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Oxazoles; Prostaglandin-Endoperoxide Synthases | 1999 |
De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1.
Topics: Adenocarcinoma; Alternative Splicing; Base Sequence; bcl-X Protein; Carboxylic Acids; Caspase 9; Caspases; Ceramides; DNA Primers; Enzyme Inhibitors; Fumonisins; Humans; Lung Neoplasms; Marine Toxins; Okadaic Acid; Oxazoles; Phosphoprotein Phosphatases; Protein Phosphatase 1; Protein Phosphatase 2; Proto-Oncogene Proteins c-bcl-2; Sphingolipids; Tumor Cells, Cultured | 2002 |
Effect of ditazole, an inhibitor of platelet aggregation, on a metastasizing tumour in mice.
Topics: Animals; Lung Neoplasms; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Oxazoles; Platelet Aggregation | 1978 |
[On the carcinogenic action of N-nitroso compounds. 6th communication: methoxymethyl-methylnitrosamine, 1-(methoxy)-ethyl-ethylnitrosamine, methoxymethyl-ethylnitrosamine, 1-(methoxy)-ethyl-methylnitrosamine, and N-nitrosooxazolidine (author's transl)].
Topics: Animals; Biotransformation; Carcinogens; Female; Lethal Dose 50; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Experimental; Nitrosamines; Nitroso Compounds; Organ Specificity; Oxazoles; Rats | 1976 |
Inhibition of experimental metastasis and cell adhesion of B16F1 melanoma cells by inhibitors of protein kinase C.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Animals; Cell Adhesion; Isoquinolines; Lung Neoplasms; Melanoma, Experimental; Membrane Proteins; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Oxazoles; Oxazolone; Phosphorylation; Piperazines; Protein Kinase C; Pyridines; Staurosporine; Time Factors | 1992 |
Effects of the combination of acivicin and cis-diamminedichloroplatinum(II) on thymidylate synthesis of A549 lung cancer cells.
Topics: Antimetabolites; Cell Line; Cisplatin; Drug Combinations; Growth Inhibitors; Humans; Isoxazoles; Lung Neoplasms; Oxazoles; Thymidine Kinase; Thymidine Monophosphate; Thymidylate Synthase; Thymine Nucleotides; Tumor Cells, Cultured | 1989 |
Phase II study of acivicin in non-small cell lung cancer: a National Cancer Institute of Canada Study.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Canada; Carcinoma, Non-Small-Cell Lung; Cognition Disorders; Drug Evaluation; Female; Hematologic Diseases; Humans; Isoxazoles; Lung Neoplasms; Male; Middle Aged; Oxazoles | 1986 |
Uptake of glutamine antimetabolites 6-diazo-5-oxo-L-norleucine (DON) and acivicin in sensitive and resistant tumor cell lines.
Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites; Azo Compounds; Biological Transport; Colonic Neoplasms; Diazooxonorleucine; Drug Resistance; Glutamine; Humans; Isoxazoles; Kinetics; Leukemia P388; Lung Neoplasms; Mice; Neoplasms, Experimental; Oxazoles; Tumor Cells, Cultured | 1988 |
Cell cycle phase perturbations by 6-diazo-5-oxo-L-norleucine and acivicin in normal and neoplastic human cell lines.
Topics: Antimetabolites; Azo Compounds; Cell Cycle; Cell Line; Colonic Neoplasms; Diazooxonorleucine; Drug Evaluation, Preclinical; Glutaminase; Glutamine; Humans; Isoxazoles; Lung Neoplasms; Neoplasms, Experimental; Oxazoles | 1987 |